From: Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea
Vaccine efficacy (%)
TD non-vaccinated
TD vaccinated
Health benefits
Punctual estim.
Expected cases
Absolute reduction of cases
42.6 (18.9–59.3)
366 (325–385)
211 (186–237)
155 (133–178)